pembrolizumab | R Documentation |
Survival data
Survival status and ctDNA levels for patients receiving pembrolizumab
data('pembrolizumab')
A data frame with 94 rows and 15 variables:
Patient ID
Age at study entry
Patient Sex
Study Cohort
Target lesion size at baseline
PD L1 percent
log of TMB
Baseline ctDNA
Did ctDNA increase or decrease from baseline to cycle 3
Objective Response
Clinical Beneficial Response
Overall survival status
Overall survival time in months
Progression free survival status
Progression free survival time in months
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.